Cargando…

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis

BACKGROUND: High-grade gliomas are the most common primary brain tumours. Pseudoprogression describes the false appearance of radiation-induced progression on MRI. A distinction should be made from true tumour progression to correctly plan treatment. However, there is wide variation of reported pseu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Abdul W., Westerlaan, Henriette E., Holtman, Gea A., Aden, Kamal M., van Laar, Peter Jan, van der Hoorn, Anouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105173/
https://www.ncbi.nlm.nih.gov/pubmed/28466127
http://dx.doi.org/10.1007/s00062-017-0584-x
_version_ 1783349612095995904
author Abbasi, Abdul W.
Westerlaan, Henriette E.
Holtman, Gea A.
Aden, Kamal M.
van Laar, Peter Jan
van der Hoorn, Anouk
author_facet Abbasi, Abdul W.
Westerlaan, Henriette E.
Holtman, Gea A.
Aden, Kamal M.
van Laar, Peter Jan
van der Hoorn, Anouk
author_sort Abbasi, Abdul W.
collection PubMed
description BACKGROUND: High-grade gliomas are the most common primary brain tumours. Pseudoprogression describes the false appearance of radiation-induced progression on MRI. A distinction should be made from true tumour progression to correctly plan treatment. However, there is wide variation of reported pseudoprogression. We thus aimed to establish the incidence of pseudoprogression and tumour progression in high-grade glioma patients with a systematic review and meta-analysis. METHODS: We searched PubMed, Embase and Web of Science on the incidence of pseudoprogression and tumour progression in adult high-grade glioma patients from 2005, the latest on 8 October 2014. Histology or imaging follow-up was used as reference standard. Extracted data included number of patients with worsening of imaging findings on T1 postcontrast or T2/FLAIR, pseudoprogression and tumour progression. Study quality was assessed. Heterogeneity was tested with I (2). Pooling of the results was done with random models using Metaprop in STATA (StataCorp. Stata Statistical Software. College Station, TX: StataCorp LP). RESULTS: We identified 73 studies. MRI progression occurred in 2603 patients. Of these, 36% (95% confidence interval [CI] 33–40%) demonstrated pseudoprogression, 60% (95%CI 56–64%) tumour progression and unknown outcome was present in the remaining 4% of the patients (range 1–37%). CONCLUSION: This meta-analysis demonstrated for the first time a notably high pooled incidence of pseudoprogression in patients with a form of progression across the available literature. This highlighted the full extent of the problem of the currently conventional MRI-based Response Assessment in Neuro-Oncology (RANO) criteria for treatment evaluation in high-grade gliomas. This underscores the need for more accurate treatment evaluation using advanced imaging to improve diagnostic accuracy and therapeutic approach. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1007/s00062-017-0584-x) contains supplementary material, which is available to authorized users. It contains the characteristics of the included studies (supplementary table 1) and a full search strategy (see supplementary search strategy).
format Online
Article
Text
id pubmed-6105173
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-61051732018-08-30 Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis Abbasi, Abdul W. Westerlaan, Henriette E. Holtman, Gea A. Aden, Kamal M. van Laar, Peter Jan van der Hoorn, Anouk Clin Neuroradiol Original Article BACKGROUND: High-grade gliomas are the most common primary brain tumours. Pseudoprogression describes the false appearance of radiation-induced progression on MRI. A distinction should be made from true tumour progression to correctly plan treatment. However, there is wide variation of reported pseudoprogression. We thus aimed to establish the incidence of pseudoprogression and tumour progression in high-grade glioma patients with a systematic review and meta-analysis. METHODS: We searched PubMed, Embase and Web of Science on the incidence of pseudoprogression and tumour progression in adult high-grade glioma patients from 2005, the latest on 8 October 2014. Histology or imaging follow-up was used as reference standard. Extracted data included number of patients with worsening of imaging findings on T1 postcontrast or T2/FLAIR, pseudoprogression and tumour progression. Study quality was assessed. Heterogeneity was tested with I (2). Pooling of the results was done with random models using Metaprop in STATA (StataCorp. Stata Statistical Software. College Station, TX: StataCorp LP). RESULTS: We identified 73 studies. MRI progression occurred in 2603 patients. Of these, 36% (95% confidence interval [CI] 33–40%) demonstrated pseudoprogression, 60% (95%CI 56–64%) tumour progression and unknown outcome was present in the remaining 4% of the patients (range 1–37%). CONCLUSION: This meta-analysis demonstrated for the first time a notably high pooled incidence of pseudoprogression in patients with a form of progression across the available literature. This highlighted the full extent of the problem of the currently conventional MRI-based Response Assessment in Neuro-Oncology (RANO) criteria for treatment evaluation in high-grade gliomas. This underscores the need for more accurate treatment evaluation using advanced imaging to improve diagnostic accuracy and therapeutic approach. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1007/s00062-017-0584-x) contains supplementary material, which is available to authorized users. It contains the characteristics of the included studies (supplementary table 1) and a full search strategy (see supplementary search strategy). Springer Berlin Heidelberg 2017-05-02 2018 /pmc/articles/PMC6105173/ /pubmed/28466127 http://dx.doi.org/10.1007/s00062-017-0584-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Abbasi, Abdul W.
Westerlaan, Henriette E.
Holtman, Gea A.
Aden, Kamal M.
van Laar, Peter Jan
van der Hoorn, Anouk
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title_full Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title_fullStr Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title_full_unstemmed Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title_short Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
title_sort incidence of tumour progression and pseudoprogression in high-grade gliomas: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105173/
https://www.ncbi.nlm.nih.gov/pubmed/28466127
http://dx.doi.org/10.1007/s00062-017-0584-x
work_keys_str_mv AT abbasiabdulw incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis
AT westerlaanhenriettee incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis
AT holtmangeaa incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis
AT adenkamalm incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis
AT vanlaarpeterjan incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis
AT vanderhoornanouk incidenceoftumourprogressionandpseudoprogressioninhighgradegliomasasystematicreviewandmetaanalysis